Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy targetKamal Mandal, Arun P. Wiita, Michael R. Hoopmann et al.|Nature Cancer|2023Cited by 39
LNK/<i>SH2B3</i> as a novel driver in juvenile myelomonocytic leukemiaAstrid Wintering, Elliot Stieglitz, Anna Hecht et al.|Haematologica|2023Cited by 8